The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...

The work, described in a preprint paper, has the potential to create new treatments and accelerate research into artificially ...

On Tuesday, Longitude Health announced the appointment of Vishal Agrawal, M.D., to the post of CEO. He succeeds Brett Moraski ...

Belén Garijo, who steered Merck KGaA through the COVID-19 pandemic, will step down as CEO of the German healthcare and electronics conglomerate. Garijo will end her five-year tenure as planned by the ...

ZURICH, Sept 22 (Reuters) - Roche (ROG.S), opens new tab Chief Executive Thomas Schinecker and other senior executives from the Swiss pharmaceuticals industry will meet with the government on Monday ...

“Cisco has a market cap of hundreds of billions of dollars,” Chapman said, in an audio snippet attached to Shkreli’s post, adding that, “At minimum, the future of IonQ looks like that and the ceiling ...

The first woman to helm a Big Pharma will be stepping down in January as GSK’s Emma Walmsley moves aside for her chief commercial officer Luke Miels. Walmsley, 56, who became the British pharma’s CEO ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye ...

ZURICH (Reuters) -Roche Chief Executive Thomas Schinecker and other senior executives from the Swiss pharmaceuticals industry will meet with the government on Monday to discuss the threat U.S. tariffs ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye diseases, announces today that its half ...

Speculation about succession at Sun Pharmaceutical Industries, India’s most valuable drug maker, was put to rest this year when its billionaire founder, Dilip Shanghvi, made some changes at the top.

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.